Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

690
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
690
Hypertension I: Introduction01:28

Hypertension I: Introduction

1.1K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.1K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

584
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
584
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

7.0K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.0K
Blood Pressure01:30

Blood Pressure

5.4K
Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs.

Journal of the Endocrine Society·2026
Same author

Safety and efficacy of lorundrostat, an aldosterone synthase inhibitor, in patients with uncontrolled hypertension: A systematic review and meta-analysis.

Medicine·2026
Same author

Anti-Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea.

Chronic diseases and translational medicine·2026
Same author

Type 1 Diabetes and Cardiovascular Risk: The Current Management Strategies.

Reviews in cardiovascular medicine·2026
Same author

From Induction to Maintenance? Rethinking GLP-1-Based Obesity Pharmacotherapy in the Era of Oral Agents.

Diabetes, obesity & metabolism·2026
Same author

Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis.

Endocrinology, diabetes & metabolism·2026

Related Experiment Video

Updated: Mar 11, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K

Endocrine Hypertension: A Practical Approach.

Joseph M Pappachan1, Harit N Buch2

  • 1Department of Endocrinology & Diabetes, New Cross Hospital, The Royal Wolverhampton Hospital NHS Trust, Wolverhampton, WV10 0QP, UK. drpappachan@yahoo.co.in.

Advances in Experimental Medicine and Biology
|November 20, 2016
PubMed
Summary
This summary is machine-generated.

Endocrine hypertension, often silent, is a significant cause of secondary high blood pressure. Early diagnosis and treatment of conditions like primary aldosteronism can reduce related health risks.

Keywords:
AcromegalyCongenital adrenal hyperplasiaCushing’s syndromeEndocrine hypertensionLiddle syndromePheochromocytomaPrimary aldosteronismPrimary hyperparathyroidismThyroid disease

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.3K

Related Experiment Videos

Last Updated: Mar 11, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.3K

Area of Science:

  • Endocrinology
  • Nephrology
  • Hypertension Research

Background:

  • Endocrine disorders are a significant cause of secondary hypertension.
  • Many cases of endocrine hypertension are asymptomatic until diagnosed.
  • Primary aldosteronism is the most common cause of endocrine hypertension.

Purpose of the Study:

  • To provide a comprehensive overview of endocrine hypertension.
  • To outline a practical approach to diagnosing endocrine hypertension.
  • To discuss the management of endocrine hypertension.

Main Methods:

  • Review of current literature on endocrine hypertension.
  • Analysis of diagnostic criteria for various endocrine causes.
  • Synthesis of treatment guidelines for endocrine hypertension.

Main Results:

  • Primary aldosteronism, congenital adrenal hyperplasia, Liddle syndrome, pheochromocytomas, Cushing's syndrome, acromegaly, thyroid diseases, and primary hyperparathyroidism are key causes.
  • Early identification and management are crucial for reducing morbidity and mortality.
  • A systematic diagnostic and management strategy is essential.

Conclusions:

  • Endocrine hypertension requires careful evaluation to identify underlying causes.
  • Timely intervention can significantly improve patient outcomes.
  • This article serves as a practical guide for clinicians.